Literature DB >> 484647

Outcome of normal and dysfunctional labor in different racial groups.

M H Thom, K K Chan, J W Studd.   

Abstract

Spontaneous labor in patients of different racial groups has been studied relating progress and outcome to whether labor was dysfunctional as defined by the partogram and action line. Forty-three percent of primigravidas and 17.6 to 25.8% of multigravidas passed the action line and had a lower admission cervical dilatation and a longer observed first stage than those patients whose labor progress remained to the left of the action line. White and black primigravidas whose labor progressed to the right of the action line had lower 1 and 5 minute Apgar scores and delivered heavier babies than those to the left. The cesarean section rates were 1.6% and 1.4% (left) and 7.6% and 18.2% (right) in white and black primigravidas, respectively. The cesarean section rate was significantly higher in black primigravidas irrespective of the relationship to the action line due to the high incidence of the complications of hypertension such as fetal distress and abruptio placentae in those in normal labor as well as those in dysfunctional labor due to cephalopelvic disproportion in those patients whose cervimetric progress went to the right of the action line.

Entities:  

Mesh:

Year:  1979        PMID: 484647     DOI: 10.1016/0002-9378(79)90438-1

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  3 in total

Review 1.  Sodium transport inhibitors in pregnancy-induced hypertension.

Authors:  L Poston
Journal:  Cardiovasc Drugs Ther       Date:  1990-03       Impact factor: 3.727

2.  Predictors of cesarean section delivery among college-educated black and white women, Davidson County, Tennessee, 1990-1994.

Authors:  A O Scott-Wright; T M Flanagan; R M Wrona
Journal:  J Natl Med Assoc       Date:  1999-05       Impact factor: 1.798

3.  Racial/ethnic differences in the likelihood of cesarean delivery, California.

Authors:  P Braveman; S Egerter; F Edmonston; M Verdon
Journal:  Am J Public Health       Date:  1995-05       Impact factor: 9.308

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.